⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
globenewswire.com
NTHI
LLY
BIIB
BBIO
BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026
globenewswire.com
BBIO
GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic Protoporphyria
businesswire.com
BBIO
Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight
globenewswire.com
TMO
CRL
BBIO
PTC
BMRA
BIIB
PFE
DKSH Enters Strategic Distribution Partnership with BridgeBio to Support Regulatory Evaluation and Potential Patient Access to Transthyretin Stabilizer for ATTR-CM in Selected Asia Pacific Markets
prnewswire.com
BBIO
Form 8-K
sec.gov
BBIO
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
globenewswire.com
BBIO
Invisible No More: Low Awareness, Missed Diagnoses -- New Survey Sheds Light on ATTR-CM's Hidden Impact on Women
prnewswire.com
BBIO
Form 8-K
sec.gov
BBIO